Tier 3 reports for 'TAMSULOSIN HYDROCHLORIDE' and 'tablet (extended-release)'
Tier 3 Drug Shortages
10 reports found
Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
---|---|---|---|---|---|
TEVA-TAMSULOSIN CR | TEVA CANADA LIMITED | 2024-11-25 | 0.4MG | Resolved | 209148 |
APO-TAMSULOSIN CR | APOTEX INC | 2024-11-15 | 0.4MG | Resolved | 200177 |
APO-TAMSULOSIN CR | APOTEX INC | 2024-11-15 | 0.4MG | Resolved | 205480 |
APO-TAMSULOSIN CR | APOTEX INC | 2024-11-15 | 0.4MG | Resolved | 209286 |
TEVA-TAMSULOSIN CR | TEVA CANADA LIMITED | 2024-10-15 | 0.4MG | Resolved | 190785 |
TAMSULOSIN CR | PRO DOC LIMITEE | 2024-09-20 | 0.4MG | Resolved | 215019 |
TAMSULOSIN CR | SANIS HEALTH INC | 2024-07-05 | 0.4MG | Resolved | 211102 |
SANDOZ TAMSULOSIN CR | SANDOZ CANADA INCORPORATED | 2024-04-09 | 0.4MG | Resolved | 216208 |
TAMSULOSIN CR | SANIS HEALTH INC | 2024-02-29 | 0.4MG | Resolved | 216290 |
TAMSULOSIN CR | SIVEM PHARMACEUTICALS ULC | 2024-02-19 | 0.4MG | Actual shortage | 211157 |
Showing 1 to 10 of 10
Tier 3 Drug Discontinuations
1 reports found
Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
---|---|---|---|---|---|
FLOMAX CR | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 2024-02-17 | 0.4MG | Discontinued | 213714 |
Showing 1 to 1 of 1